Solray D3 + K2 Liposome Spray
Solray D3 + K2 has advanced nanosphere technology concentrated in a liposome spray to support maximum absorption.*
Vitamin D3 and Vitamin K2 (MK-7) deficiency is a worldwide epidemic. Over 1 billion people are at risk for its associated conditions beyond this winter's viral concerns. Almost daily, references to vitamin D dominate the headlines. Paradoxically, very little is being said about Vitamin K2.
There is overwhelming evidence confirming that the safety of vitamin D is dependent on adequate vitamin K2 (MK-7).
Vitamin K is the name of a group of compounds that are all related. The first one discovered was Phylloquinone or K1. K1 is the form in which vitamin K produces clotting factors. Produced by plants and algae, K1 is found in green leafy vegetables such as broccoli, kale, and Swiss chard and in plant oils such as canola and soybean oil.
Most research has turned to the more effective menaquinones or vitamin K2 in the last decade. Supplemental vitamin K2 exists in several forms. The most common ones are the synthetic menaquinone-4 (MK-4) and the natural menaquinone-7 (MK-7).
Recent studies have shown the more expensive vitamin MK-7 to be more complete, may have additional heart condition benefits, and may include inhibiting calcium deposits in the arteries. MK-4 must be applied in very high pharmacological doses (milligrams) to demonstrate bone and heart health benefits. In the case of MK-7, doses in micrograms – 1000x less are sufficient for a significant bioactive effect.
The longer half-life of MK-7 results in significantly better accumulation compared to MK-4. Research shows that MK-7 has six times better absorption in only eight days.
The long-chain menaquinones (especially MK-7) are the most desirable as they are nearly completely absorbed (the body requires smaller doses) and stay in the blood for the longest time. This means vitamin K2 can also be available for tissues outside the liver, bones, arteries, and soft tissues. K2 has been reported to decrease serum cholesterol and cholesterol deposits in the aorta, contributing to the suppression of atherosclerosis.
Vitamin K2 (MK-7) has been linked to reduced coronary heart disease. One extensive and significant study conducted in the Netherlands in 2004 followed 4800 healthy men and women for ten years. It found vitamin K2 reduced the risk of coronary heart disease mortality by 50%; aortic calcification was also reduced by 30-40% in the famous Rotterdam study.
